Author/Creator: Gallwitz, Baptist - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Gallwitz, Baptist

1. A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes. Issue 12 (2nd December 2017)

Authors:: Gallwitz, Baptist
Journal:: Expert opinion on drug safety
Issue:: Volume 16:Issue 12(2017:Dec.)
Page Start:: 1399
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c. Issue 2 (5th October 2017)

Authors:: Gallwitz, Baptist; Dagogo‐Jack, Samuel; Thieu, Vivian; Garcia‐Perez, Luis‐Emilio; Pavo, Imre; Yu, Maria; Robertson, Kenneth E.; Zhang, Nan; Giorgino, Francesco
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 20:Issue 2(2018)
Page Start:: 409
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of MK‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open‐label clinical trial. Issue 9 (5th June 2018)

Authors:: Home, Philip D.; Lam, Raymond L. H.; Carofano, Wendy L.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rosenstock, Julio; Hollander, Priscilla A.; Gallwitz, Baptist
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 20:Issue 9(2018)
Page Start:: 2220
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Efficacy and safety of MK‐1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open‐label clinical trial. Issue 9 (10th June 2018)

Authors:: Hollander, Priscilla A.; Carofano, Wendy L.; Lam, Raymond L.H.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rendell, Marc S.; Home, Philip D.; Gallwitz, Baptist; Rosenstock, Julio
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 20:Issue 9(2018)
Page Start:: 2229
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advances. Issue 1 (February 2016)

Authors:: Gallwitz, Baptist
Journal:: Current opinion in endocrinology, diabetes and obesity
Issue:: Volume 23:Issue 1(2016:Feb.)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Incretin for the continuing treatment of secondary failure to metformin in Type 2 diabetes. (July 2013)

Authors:: Gallwitz, Baptist
Journal:: Diabetes management
Issue:: Volume 3:Number 4(2013)
Page Start:: 323
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Linagliptin as add‐on to empagliflozin and metformin in patients with type 2 diabetes: Two 24‐week randomized, double‐blind, double‐dummy, parallel‐group trials. Issue 2 (24th November 2016)

Authors:: Tinahones, Francisco J.; Gallwitz, Baptist; Nordaby, Matias; Götz, Sophia; Maldonado‐Lutomirsky, Mario; Woerle, Hans J.; Broedl, Uli C.
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 19:Issue 2(2017)
Page Start:: 266
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Linagliptin plus metformin in patients with newly diagnosed type 2 diabetes and marked hyperglycemia. Issue 8 (16th November 2016)

Authors:: Ross, Stuart A.; Caballero, A. Enrique; Del Prato, Stefano; Gallwitz, Baptist; Lewis-D'Agostino, Diane; Bailes, Zelie; Thiemann, Sandra; Patel, Sanjay; Woerle, Hans-Juergen; von Eynatten, Maximilian
Journal:: Postgraduate medicine
Issue:: Volume 128:Issue 8(2016)
Page Start:: 747
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial. Issue 3 (13th November 2017)

Authors:: Ma, Ronald CW; Del Prato, Stefano; Gallwitz, Baptist; Shivane, Vyankatesh K; Lewis‐D'Agostino, Diane; Bailes, Zelie; Patel, Sanjay; Lee, Jisoo; von Eynatten, Maximilian; Di Domenico, Maximiliano; Ross, Stuart A
Journal:: Journal of diabetes investigation
Issue:: Volume 9:Issue 3(2018)
Page Start:: 579
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. Safety and efficacy of linagliptin in type 2 diabetes patients with common renal and cardiovascular risk factors. (June 2013)

Authors:: Gallwitz, Baptist
Journal:: Therapeutic advances in endocrinology and metabolism
Issue:: Volume 4:Number 3(2013)
Page Start:: 95
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗